Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil

被引:7
|
作者
Mistro, Sostenes [1 ,2 ]
Rodrigues, Marlon [2 ]
Rosa, Lorena [2 ]
Camargo, Marianne [2 ]
Badaro, Roberto [1 ,3 ]
机构
[1] Univ Fed Bahia, Program Postgrad Med & Hlth, Salvador, BA, Brazil
[2] Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, BA, Brazil
[3] Univ Fed Bahia, Dept Med & Diag, Salvador, BA, Brazil
关键词
leishmaniasis; Brazil; liposomal amphotericin B; access to medication; pharmacoeconomics; developing countries; VISCERAL LEISHMANIASIS; COMBINATION THERAPIES; EMULSION;
D O I
10.1111/tmi.12697
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:692 / 693
页数:2
相关论文
共 50 条
  • [41] Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review
    Mosimann, Vincent
    Neumayr, Andreas
    Paris, Daniel H.
    Blum, Johannes
    [J]. ACTA TROPICA, 2018, 182 : 246 - 250
  • [42] LIPOSOMAL AMPHOTERICIN-B FOR LEISHMANIASIS TREATMENT OF AIDS PATIENTS UNRESPONSIVE TO ANTIMONIUM COMPOUNDS
    LAZANAS, MC
    TSEKES, GA
    PAPANDREOU, S
    HARHALAKIS, N
    SCANDALI, A
    NIKIFORAKIS, E
    SAROGLOU, G
    [J]. AIDS, 1993, 7 (07) : 1018 - 1019
  • [43] Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol
    Khodabandeh, Mahmoud
    Rostami, Ali
    Borhani, Katayoun
    Gamble, H. Ray
    Mohammadi, Mohsen
    [J]. PARASITOLOGY INTERNATIONAL, 2019, 72
  • [44] SUCCESSFUL TREATMENT OF ANTIMONY-RESISTANT CUTANEOUS LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B
    TORRECISNEROS, J
    PRADA, JL
    VILLANUEVA, JL
    VALVERDE, F
    SANCHEZGUIJO, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) : 1024 - 1025
  • [45] A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan
    Mueller, Marius
    Balasegaram, Manica
    Koummuki, Youssif
    Ritmeijer, Koert
    Santana, Muriel Ramirez
    Davidson, Robert
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 811 - 815
  • [46] Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients
    Rocio, Carolina
    Amato, Valdir Sabbaga
    Camargo, Raphael A.
    Tuon, Felipe F.
    Nicodemo, Antonio Carlos
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (03) : 176 - 178
  • [47] Successful Treatment of Childhood Cutaneous Leishmaniasis with Liposomal Amphotericin B: Report of Two Cases
    del Rosal, Teresa
    Baquero Artigao, Fernando
    Garcia Miguel, Maria J.
    de Lucas, Raul
    del Castillo, Fernando
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2010, 56 (02) : 122 - 124
  • [48] Different liposomal amphotericin B formulations for visceral leishmaniasis Reply
    Kshirsagar, Nilima
    [J]. LANCET GLOBAL HEALTH, 2014, 2 (08): : E450 - E450
  • [49] Recidivans cutaneous leishmaniasis unresponsive to liposomal amphotericin B (AmBisome®)
    Gündüz, K
    Afsar, S
    Ayhan, S
    Kandiloglu, AR
    Türel, A
    Filiz, EE
    Ok, ÜZ
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2000, 14 (01) : 11 - 13
  • [50] Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis
    Yardley, V
    Croft, SL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) : 752 - 756